MIROCALS consortium is formed by 12 organisations in the EU to conduct a phase II Proof of Concept / Proof of Mechanism Clinical Trial aiming to test the interleukin-2 (IL-2) as treatment for amyotrophic lateral sclerosis (ALS).

The science of the project is coordinated by Dr Gilbert Bensimon of the University Hospital of Nimes (France) which is the trial sponsor, and Professor P. Nigel Leigh of the Brighton and Sussex Medical School (UK).

Around them, the MIROCALS consortium brings together a strong partnership of: leading scientists and clinicians from six European laboratories in France, Italy, Sweden and UK; two clinical research organisations for professional biobanking and trial regulatory-compliant monitoring; the MND Association one of the most active patients’ associations in the field of neurodegeneration worldwide and an EU project management company.

MIROCALS is a 4-year collaborative research project started in September 2015 and supported by the European Union’s Horizon 2020 research and innovation Programme.

 

Logo CHU Logo InsermTransfert

University Hospital of Nimes
Nîmes, France

Inserm Transfert
Paris, France

ICON logo jpg original Généthon EN Q

ICON plc
Ireland

Genethon
Evry, France

HumanitasRH 1498139 ny logo en high

Humanitas Research Hospital
Milan, Italy

University of Gothenburg
Sweden

US small pos k tuoslogo key

University of Sussex
UK

University of Sheffield
UK

kingslondon queen mary

King's College London
London, UK

Queen Mary University
London, UK

MNDA ENGLISH PMS BLUE ORANGE  wgk welcome logo

Motor Neurone Disease Association
UK

WGK Consultancy Ltd
UK

News

MIROCALS 1st General Assembly meeting in Brighton, June 9 & 10th 2016

This meeting gathered all MIROCALS partners for presenting the progress made since the launch of the project a year ago as well as the next achievements for the coming year. 

First participant recruited to MIROCALS trial

The MIROCALS consortium is delighted to announce that the first participant has been recruited to the MIROCALS trial, at Hospices Civils de Lyon, France.

Read more.

MIROCALS kick-off meeting in Paris, September 17-18th 2015

This meeting gathered all MIROCALS partners for fine-tuning the planned work programme, in the presence of the EC project officer, and members of the Independent Scientific Advisory Board of the project.

europe

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 633413.